Testosterone Cypionate Injectable Recalled for Lack of Sterility Assurance
Talon Compounding Pharmacy is recalling testosterone cypionate 100 mg/mL injectable in 12 lots due to lack of assurance of sterility. The affected product was distributed across the United States.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall. Non-sterile injectable products pose a significant risk of serious infection, which meets the Severe category criteria for products with potential for serious injury even without reported cases.
Plain-English summary
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling testosterone cypionate 100 mg/mL injectable (Rx only) distributed under their name from their San Antonio, Texas location. The recall affects 168 vials across 12 lots with various beyond-use dates ranging from November 2021 through March 2022.
The recall is due to lack of assurance of sterility. Non-sterile injectables pose a risk of infection when administered.
The product was distributed throughout the United States, including Washington, D.C. and Puerto Rico. Patients using this product should consult their healthcare provider immediately regarding their treatment.
The affected lot numbers and corresponding beyond-use dates are: T0204272021:49 (10/24/2021), T0206142021:55 (12/11/2021), T0209082021:74 (03/07/2022), T0506212021:52 (12/18/2021), T0207082021:41 (01/04/2022), T0208112021:07 (02/07/2022), T0206012021:26 (11/28/2021), T0507122021:00 (01/08/2022), T0505112021:58 (11/07/2021), T0205182021:56 (11/14/2021), T0506102021:88 (12/07/2021), and T0508182021:56 (02/14/2022).
The recalled product
- Product
- TESTOSTERONE CYPIONATE 100MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Affected units
- 168
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lot: T0204272021:49 BUD: 10/24/2021
- T0206142021:55 BUD: 12/11/2021
- T0209082021:74 BUD: 03/07/2022
- T0506212021:52 BUD: 12/18/2021
- T0207082021:41 BUD: 01/04/2022
- T0208112021:07 BUD: 02/07/2022
- T0206012021:26 BUD: 11/28/2021
- T0507122021:00 BUD: 01/08/2022
- T0505112021:58 BUD: 11/07/2021
- T0205182021:56 BUD: 11/14/2021
- T0506102021:88 BUD: 12/07/2021
- T0508182021:56 BUD: 02/14/2022
Distribution
Part of a larger recall action
This product is one of 130 recalled by Vita Pharmacy, LLC dba Talon Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 130 products in this recall →Related recalls
Same manufacturer · Vita Pharmacy, LLC dba Talon Compounding Pharmacy
See all →- HighInjectable testosterone and dutasteride product recall for sterility assurance failure
FDA (Drugs) · 2021-11-17
- HighIC B Complex Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17
- SevereTRI-MIX Injectable by Talon Compounding Pharmacy Recalled for Sterility Assurance
FDA (Drugs) · 2021-11-17
- SevereInjectable Steroid Combination Product Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17
- HighTestosterone Bi-Blend Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22